{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:43:13Z","timestamp":1790811793582,"version":"4.1.0"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Retinal and Eye Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.preteyeres.2025.101376","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T21:51:07Z","timestamp":1749160267000},"page":"101376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Shining light on CRISPR\/Cas9 therapeutics for inherited retinal diseases"],"prefix":"10.1016","volume":"107","author":[{"given":"A.B.","family":"Geiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Staker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.G.","family":"Wensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Casson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-5770","authenticated-orcid":false,"given":"P.Q.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.preteyeres.2025.101376_bib1","doi-asserted-by":"crossref","first-page":"10785","DOI":"10.1093\/nar\/gkab792","article-title":"Optimized nickase- and nuclease-based prime editing in human and mouse cells","volume":"49","author":"Adikusuma","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib3","article-title":"Using synthetically engineered guide RNAs to enhance CRISPR genome editing systems in mammalian cells","author":"Allen","year":"2020","journal-title":"Front. Genome"},{"key":"10.1016\/j.preteyeres.2025.101376_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nbt.4317","article-title":"Predicting the mutations generated by repair of Cas9-induced double-strand breaks","volume":"37","author":"Allen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib5","doi-asserted-by":"crossref","first-page":"11372","DOI":"10.1128\/JVI.01327-07","article-title":"Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors","volume":"81","author":"Allocca","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo","author":"An","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib7","article-title":"Programmable deletion, replacement, integration and inversion of large DNA sequences with twin prime editing","author":"Anzalone","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nat. Lond."},{"key":"10.1016\/j.preteyeres.2025.101376_bib10","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/pharmaceutics14081605","article-title":"Lentiviral vectors for ocular gene therapy","volume":"14","author":"Arsenijevic","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2025.101376_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.omtm.2023.08.007","article-title":"Toward lentiviral vectors for antiangiogenic ocular gene therapy","volume":"30","author":"Askou","year":"2023","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.preteyeres.2025.101376_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12974-024-03175-8","article-title":"CD44 signaling in M\u00fcller cells impacts photoreceptor function and survival in healthy and diseased retinas","volume":"21","author":"Ayten","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.preteyeres.2025.101376_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41583-019-0242-1","article-title":"Understanding the retinal basis of vision across species","volume":"21","author":"Baden","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib15","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.4103\/ijo.IJO_1010_22","article-title":"Commentary: CRISPR gene editing for inherited retinal dystrophies: towards clinical translation","volume":"70","author":"Bansal","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2025.101376_bib17","doi-asserted-by":"crossref","first-page":"19969","DOI":"10.1038\/srep19969","article-title":"Precision medicine: genetic repair of retinitis pigmentosa in patient-derived stem cells","volume":"6","author":"Bassuk","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101376_bib18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1113\/jphysiol.1979.sp012716","article-title":"Responses of retinal rods to single photons","volume":"288","author":"Baylor","year":"1979","journal-title":"J. Physiol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113467","article-title":"Inherited retinal diseases","volume":"23","author":"Ben-Yosef","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149473","article-title":"Dominant retinitis pigmentosa, p.Gly56Arg mutation in NR2E3: phenotype in a large cohort of 24 cases","volume":"11","author":"Blanco-Kelly","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101376_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5614","article-title":"A gene therapy for inherited blindness using dCas9-VPR-mediated transcriptional activation","volume":"6","author":"B\u00f6hm","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2025.101376_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/hum.2016.085","article-title":"Highly efficient delivery of adeno-associated viral vectors to the primate retina","volume":"27","author":"Boye","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep41937","article-title":"Unravelling the genetic basis of simplex Retinitis Pigmentosa cases","volume":"7","author":"Bravo-Gil","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101376_bib24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/ceo.14110","article-title":"Victorian evolution of inherited retinal diseases natural history registry (VENTURE study): rationale, methodology and initial participant characteristics","volume":"50","author":"Britten\u2010Jones","year":"2022","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib25","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ymthe.2017.05.015","article-title":"Using CRISPR-cas9 to generate gene-corrected autologous iPSCs for the treatment of inherited retinal degeneration","volume":"25","author":"Burnight","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1089\/crispr.2023.0039","article-title":"CRISPRi-mediated treatment of dominant rhodopsin-associated retinitis pigmentosa","volume":"6","author":"Burnight","year":"2023","journal-title":"CRISPR J."},{"key":"10.1016\/j.preteyeres.2025.101376_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mt.2014.181","article-title":"The expression pattern of systemically injected AAV9 in the developing mouse retina is determined by age","volume":"23","author":"Byrne","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib28","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.3390\/ijms21082730","article-title":"Comparative analysis of functional and structural decline in retinitis pigmentosas","volume":"21","author":"Cabral","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib29","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1096\/fj.09-139147","article-title":"Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa","volume":"24","author":"Cai","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.preteyeres.2025.101376_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005290","article-title":"A partial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles","volume":"4","author":"Cai","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101376_bib31","doi-asserted-by":"crossref","first-page":"eaav3335","DOI":"10.1126\/sciadv.aav3335","article-title":"In vivo genome editing rescues photoreceptor degeneration via a Cas9\/RecA-mediated homology-directed repair pathway","volume":"5","author":"Cai","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2025.101376_bib32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nmeth.3312","article-title":"Highly efficient Cas9-mediated transcriptional programming","volume":"12","author":"Chavez","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.preteyeres.2025.101376_bib33","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41565-019-0539-2","article-title":"A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib34","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","article-title":"Enhanced prime editing systems by manipulating cellular determinants of editing outcomes","volume":"184","author":"Chen","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2025.101376_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/gr.162339.113","article-title":"Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases","volume":"24","author":"Cho","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib36","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41467-022-29490-3","article-title":"In vivo base editing rescues cone photoreceptors in a mouse model of early-onset inherited retinal degeneration","volume":"13","author":"Choi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/gt.2016.27","article-title":"Lentivirus pre-packed with Cas9 protein for safer gene editing","volume":"23","author":"Choi","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib38","article-title":"Dual supramolecular nanoparticle vectors enable CRISPR\/Cas9-Mediated knockin of retinoschisin 1 gene-A potential nonviral therapeutic solution for X-linked juvenile retinoschisis","volume":"7","author":"Chou","year":"2020","journal-title":"Adv. Sci. Weinh. Baden-Wurtt. Ger."},{"key":"10.1016\/j.preteyeres.2025.101376_bib39","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ymthe.2020.05.002","article-title":"Mutation-independent allele-specific editing by CRISPR-cas9, a novel approach to treat autosomal dominant disease","volume":"28","author":"Christie","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib40","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1073\/pnas.95.12.7103","article-title":"Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man","volume":"95","author":"Cideciyan","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib41","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101376_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.inmuno.2012.08.002","article-title":"Virus-like particle-based vaccines for animal viral infections","volume":"32","author":"Crisci","year":"2013","journal-title":"Inmunol. Barc. Spain"},{"key":"10.1016\/j.preteyeres.2025.101376_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1566523054546224","article-title":"Altering the tropism of lentiviral vectors through pseudotyping","volume":"5","author":"Cronin","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib44","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2147\/OPTH.S365486","article-title":"Retinitis pigmentosa: burden of disease and current unmet needs","volume":"16","author":"Cross","year":"2022","journal-title":"Clin. Ophthalmol. Auckl. NZ"},{"key":"10.1016\/j.preteyeres.2025.101376_bib45","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.2147\/OPTH.S370032","article-title":"Current and future treatment of retinitis pigmentosa","volume":"16","author":"Cross","year":"2022","journal-title":"Clin. Ophthalmol. Auckl. NZ"},{"key":"10.1016\/j.preteyeres.2025.101376_bib46","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017129","article-title":"Genes and mutations causing autosomal dominant retinitis pigmentosa","volume":"5","author":"Daiger","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.preteyeres.2025.101376_bib47","article-title":"Efficient prime editing in mouse brain, liver and heart with dual AAVs","author":"Davis","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib48","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41551-022-00911-4","article-title":"Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors","volume":"6","author":"Davis","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.preteyeres.2025.101376_bib49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-vision-082114-035334","article-title":"Functional circuitry of the retina","volume":"1","author":"Demb","year":"2015","journal-title":"Annu. Rev. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejpb.2019.05.023","article-title":"The obstacle course to the inner retina: hyaluronic acid-coated lipoplexes cross the vitreous but fail to overcome the inner limiting membrane","volume":"141","author":"Devoldere","year":"2019","journal-title":"Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV"},{"key":"10.1016\/j.preteyeres.2025.101376_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22052607","article-title":"Allele-specific knockout by crispr\/cas to treat autosomal dominant retinitis pigmentosa caused by the g56r mutation in nr2e3","volume":"22","author":"Diakatou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib52","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.cell.2023.07.039","article-title":"Phage-assisted evolution and protein engineering yield compact, efficient prime editors","volume":"186","author":"Doman","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2025.101376_bib53","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","article-title":"Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors","volume":"38","author":"Doman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","article-title":"The promise and challenge of therapeutic genome editing","volume":"578","author":"Doudna","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2025.101376_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101376_bib56","unstructured":"Editas Medicine Announces Clinical Data Demonstrating Proof Of Concept Of EDIT-101 From Phase 1\/2 BRILLIANCE Trial [WWW Document], 2022. URL https:\/\/ir.editasmedicine.com\/news-releases\/news-release-details\/editas-medicine-announces-clinical-data-demonstrating-proof."},{"key":"10.1016\/j.preteyeres.2025.101376_bib59","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/humu.20858","article-title":"Mutations in NR2E3 can cause dominant or recessive retinal degenerations in the same family","volume":"30","author":"Escher","year":"2009","journal-title":"Hum. Mutat."},{"issue":"73","key":"10.1016\/j.preteyeres.2025.101376_bib60","first-page":"A0046","article-title":"Random integration of AAV plasmid into the mouse genome following sub-retinal delivery","volume":"63","author":"Farkas","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib61","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/138920211795860107","article-title":"Retinitis pigmentosa: genes and disease mechanisms","volume":"12","author":"Ferrari","year":"2011","journal-title":"Curr. Genom."},{"key":"10.1016\/j.preteyeres.2025.101376_bib62","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/biom14010122","article-title":"Real-world safety and effectiveness of voretigene neparvovec: results up to 2 Years from the prospective, registry-based PERCEIVE study","volume":"14","author":"Fischer","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.preteyeres.2025.101376_bib63","first-page":"200","article-title":"Comparison of CRISPR-Cas13b RNA base editing approaches for USH2A-associated inherited retinal degeneration. Commun","volume":"8","author":"Fry","year":"2025","journal-title":"Biol"},{"key":"10.1016\/j.preteyeres.2025.101376_bib64","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib65","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1038\/s41467-025-57628-6","article-title":"In vivo prime editing rescues photoreceptor degeneration in nonsense mutant retinitis pigmentosa","volume":"16","author":"Fu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12886-019-1169-z","article-title":"Systematic review and meta-synthesis of coping with retinitis pigmentosa: implications for improving quality of life","volume":"19","author":"Garip","year":"2019","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib67","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nat. Lond."},{"key":"10.1016\/j.preteyeres.2025.101376_bib68","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/hmg\/ddx438","article-title":"Cas9\/sgRNA selective targeting of the P23H Rhodopsin mutant allele for treating retinitis pigmentosa by intravitreal AAV9.PHP.B-based delivery","volume":"27","author":"Giannelli","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.preteyeres.2025.101376_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108553","article-title":"ON-bipolar cell gene expression during retinal degeneration: implications for optogenetic visual restoration","volume":"207","author":"Gilhooley","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib70","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2025.101376_bib71","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1208\/s12248-018-0267-9","article-title":"Nanoparticle-based delivery of CRISPR\/Cas9 genome-editing therapeutics","volume":"20","author":"Givens","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.preteyeres.2025.101376_bib72","article-title":"Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration","author":"Greig","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib73","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.gt.3302485","article-title":"Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier","volume":"12","author":"Gr\u00fcter","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41434-021-00258-6","article-title":"Restoration of RPGR expression in vivo using CRISPR\/Cas9 gene editing","volume":"29","author":"Gumerson","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1143157","article-title":"Off-target effects in CRISPR\/Cas9 gene editing","volume":"11","author":"Guo","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib76","doi-asserted-by":"crossref","first-page":"10059","DOI":"10.1093\/nar\/gkad676","article-title":"Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR\/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification","volume":"51","author":"Haldrup","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib77","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1096\/fj.15-270363","article-title":"Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype","volume":"29","author":"Han","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.preteyeres.2025.101376_bib78","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1172\/JCI64833","article-title":"DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice","volume":"122","author":"Han","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.preteyeres.2025.101376_bib79","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib80","first-page":"34","article-title":"Frequency domain electroretinography in retinitis pigmentosa versus normal eyes","volume":"7","author":"Hassan-Karimi","year":"2012","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib81","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/13816810.2021.1913610","article-title":"Inherited retinal diseases are the most common cause of blindness in the working-age population in Australia","volume":"42","author":"Heath Jeffery","year":"2021","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.preteyeres.2025.101376_bib82","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1039\/D0BM01947J","article-title":"Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery","volume":"9","author":"Herrera","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib83","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-023-00833-2","article-title":"Lipid nanoparticle-enabled intracellular delivery of prime editors","volume":"25","author":"Herrera-Barrera","year":"2023","journal-title":"AAPS J."},{"key":"10.1016\/j.preteyeres.2025.101376_bib84","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2025.101376_bib85","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.61.4.31","article-title":"In vivo CRISPR\/Cas9-mediated genome editing mitigates photoreceptor degeneration in a mouse model of X-linked retinitis pigmentosa","volume":"61","author":"Hu","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib87","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1167\/iovs.16-19316","article-title":"AAV-mediated CRISPR\/cas gene editing of retinal cells in vivo","volume":"57","author":"Hung","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib88","doi-asserted-by":"crossref","first-page":"34150","DOI":"10.1074\/jbc.M204955200","article-title":"A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system","volume":"277","author":"Illing","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.preteyeres.2025.101376_bib89","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2025.101376_bib90","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41551-021-00788-9","article-title":"Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases","volume":"6","author":"Jang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.preteyeres.2025.101376_bib91","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg2661","article-title":"High-purity production and precise editing of DNA base editing ribonucleoproteins","volume":"7","author":"Jang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2025.101376_bib92","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012740","article-title":"Repair of strand breaks by homologous recombination","volume":"5","author":"Jasin","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib93","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 structures and mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.preteyeres.2025.101376_bib94","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101376_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247997","article-title":"Structures of Cas9 endonucleases reveal RNA-mediated conformational activation","volume":"343","author":"Jinek","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101376_bib96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.omtn.2022.11.021","article-title":"Visual function restoration in a mouse model of Leber congenital amaurosis via therapeutic base editing","volume":"31","author":"Jo","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2025.101376_bib97","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA base-editing and prime-editing","volume":"21","author":"Kantor","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib98","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12967-022-03738-4","article-title":"Potential therapeutic strategies for photoreceptor degeneration: the path to restore vision","volume":"20","author":"Karamali","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.preteyeres.2025.101376_bib99","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/genes13081327","article-title":"CRISPR DNA base editing strategies for treating retinitis pigmentosa caused by mutations in rhodopsin","volume":"13","author":"Kaukonen","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.preteyeres.2025.101376_bib100","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","article-title":"Lipid-nanoparticle-based delivery of CRISPR\/Cas9 genome-editing components","volume":"19","author":"Kazemian","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.preteyeres.2025.101376_bib101","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1016\/j.ymthe.2023.10.001","article-title":"Intravitreal injection of a rationally designed AAV capsid library in non-human primate identifies variants with enhanced retinal transduction and neutralizing antibody evasion","volume":"31","author":"Kellish","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib102","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1038\/s41467-021-26714-w","article-title":"Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice","volume":"12","author":"Kenjo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib103","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40478-021-01290-8","article-title":"Retina tissue validation of optical coherence tomography determined outer nuclear layer loss in FTLD-tau","volume":"9","author":"Kim","year":"2021","journal-title":"Acta Neuropathol. Commun"},{"key":"10.1016\/j.preteyeres.2025.101376_bib104","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41587-020-0677-y","article-title":"Predicting the efficiency of prime editing guide RNAs in human cells","volume":"39","author":"Kim","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib105","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2025.101376_bib106","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature14592","article-title":"Engineered CRISPR-Cas9 nucleases with altered PAM specificities","volume":"523","author":"Kleinstiver","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2025.101376_bib107","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","article-title":"Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction","volume":"36","author":"Koblan","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2013.08.299","article-title":"Persistence of non-viral vector mediated RPE65 expression: case for viability as a gene transfer therapy for RPE-based diseases","volume":"172","author":"Koirala","year":"2013","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.preteyeres.2025.101376_bib109","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.1038\/mtna.2016.92","article-title":"In vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based CRISPR\/Cas9 in the mouse retina","volume":"5","author":"Latella","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2025.101376_bib110","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1167\/iovs.19-27217","article-title":"Topography of neurons in the rod pathway of human retina","volume":"60","author":"Lee","year":"2019","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib111","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4103\/1673-5374.354511","article-title":"Neural and M\u00fcller glial adaptation of the retina to photoreceptor degeneration","volume":"18","author":"Leinonen","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib112","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1016\/j.cub.2017.01.016","article-title":"Inteins","volume":"27","author":"Lennon","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib113","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.preteyeres.2025.101376_bib114","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/crispr.2017.0009","article-title":"Allele-specific CRISPR-cas9 genome editing of the single-base P23H mutation for rhodopsin-associated dominant retinitis pigmentosa","volume":"1","author":"Li","year":"2018","journal-title":"CRISPR J."},{"key":"10.1016\/j.preteyeres.2025.101376_bib115","first-page":"1","article-title":"CRISPR\/Cas9 therapeutics: progress and prospects","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib116","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1631\/jzus.B2100196","article-title":"A high-efficiency and versatile CRISPR\/Cas9-mediated HDR-based biallelic editing system","volume":"23","author":"Li","year":"2022","journal-title":"J. Zhejiang Univ., Sci. B"},{"key":"10.1016\/j.preteyeres.2025.101376_bib117","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004015","article-title":"A comparison of the causes of blindness certifications in England and Wales in working age adults (16-64 years), 1999-2000 with 2009-2010","volume":"4","author":"Liew","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.preteyeres.2025.101376_bib118","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41551-020-00656-y","article-title":"Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice","volume":"5","author":"Ling","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.preteyeres.2025.101376_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2018.00691","article-title":"Methodologies for improving HDR efficiency","volume":"9","author":"Liu","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.preteyeres.2025.101376_bib120","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.84065","article-title":"Allele-specific gene-editing approach for vision loss restoration in RHO-associated retinitis pigmentosa","volume":"12","author":"Liu","year":"2023","journal-title":"eLife"},{"key":"10.1016\/j.preteyeres.2025.101376_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108405","article-title":"Spectrum-frequency and genotype\u2013phenotype analysis of rhodopsin variants","volume":"203","author":"Luo","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib122","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1093\/nar\/gkz605","article-title":"Delivering Cas9\/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient \u201chit-and-run\u201d genome editing","volume":"47","author":"Lyu","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib123","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/crispr.2020.0095","article-title":"Adenine base editor ribonucleoproteins delivered by lentivirus-like particles show high on-target base editing and undetectable RNA off-target activities","volume":"4","author":"Lyu","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.preteyeres.2025.101376_bib124","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/life10120366","article-title":"Virus-like particle mediated CRISPR\/Cas9 delivery for efficient and safe genome editing","volume":"10","author":"Lyu","year":"2020","journal-title":"Life"},{"key":"10.1016\/j.preteyeres.2025.101376_bib125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.preteyeres.2025.101376_bib126","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ymthe.2020.11.029","article-title":"Clinical perspective: treating RPE65-associated retinal dystrophy","volume":"29","author":"Maguire","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib127","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101376_bib128","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3390\/biom13020271","article-title":"Cellular and molecular mechanisms of pathogenesis underlying inherited retinal dystrophies","volume":"13","author":"Manley","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.preteyeres.2025.101376_bib129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molmed.2005.02.007","article-title":"Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy","volume":"11","author":"Mendes","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.preteyeres.2025.101376_bib130","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/gt.2009.22","article-title":"Lentiviral vectors for gene transfer into the spinal cord glial cells","volume":"16","author":"Meunier","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib131","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jconrel.2022.08.042","article-title":"LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea","volume":"350","author":"Mirjalili Mohanna","year":"2022","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.preteyeres.2025.101376_bib132","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/cmdc.201300371","article-title":"Synthesis and characterization of glycol chitosan DNA nanoparticles for retinal gene delivery","volume":"9","author":"Mitra","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.preteyeres.2025.101376_bib133","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biomaterials.2017.12.004","article-title":"Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model","volume":"157","author":"Mitra","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.preteyeres.2025.101376_bib134","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1099\/mic.0.023960-0","article-title":"Short motif sequences determine the targets of the prokaryotic CRISPR defence system","volume":"155","author":"Mojica","year":"2009","journal-title":"Microbiology"},{"key":"10.1016\/j.preteyeres.2025.101376_bib135","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.ymthe.2018.04.017","article-title":"In situ gene therapy via AAV-CRISPR-cas9-mediated targeted gene regulation","volume":"26","author":"Moreno","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib136","article-title":"In vivo proof of concept for EDIT-102: a CRISPR\/cas9-based experimental medicine for USH2A- related inherited retinal degeneration caused by mutations in exon 13","author":"Mukherjee","year":"2020","journal-title":"M\u00e9d. Sur"},{"key":"10.1016\/j.preteyeres.2025.101376_bib137","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2025.101376_bib138","first-page":"263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Sci. Am. Assoc. Adv. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib139","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/aos.13141","article-title":"A review of the mechanisms of cone degeneration in retinitis pigmentosa","volume":"94","author":"Narayan","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2024.101289","article-title":"Genetic therapies and potential therapeutic applications of CRISPR activators in the eye","volume":"102","author":"Ng","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib141","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal structure of Cas9 in complex with guide RNA and target DNA","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.preteyeres.2025.101376_bib142","article-title":"Efficient workflow for validating homology-independent targeted integration-mediated gene insertion in rod photoreceptor cells to treat dominant-negative mutations causing retinitis pigmentosa","volume":"11","author":"Onishi","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.preteyeres.2025.101376_bib143","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jconrel.2023.02.008","article-title":"Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing","volume":"355","author":"Onuma","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2025.101376_bib144","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1038\/s41467-021-25204-3","article-title":"Mirtron-mediated RNA knockdown\/replacement therapy for the treatment of dominant retinitis pigmentosa","volume":"12","author":"Orlans","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.omtm.2017.04.002","article-title":"Integrase-deficient lentiviral vector as an all-in-one platform for highly efficient CRISPR\/Cas9-Mediated gene editing","volume":"5","author":"Ortinski","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.preteyeres.2025.101376_bib146","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.omtm.2022.03.016","article-title":"AAV-PHP.eB transduces both the inner and outer retina with high efficacy in mice","volume":"25","author":"Palfi","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.preteyeres.2025.101376_bib147","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1038\/s41467-022-31543-6","article-title":"Massively targeted evaluation of therapeutic CRISPR off-targets in cells","volume":"13","author":"Pan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib148","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","article-title":"Lipid nanoparticles for delivery of messenger RNA to the back of the eye","volume":"303","author":"Patel","year":"2019","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.preteyeres.2025.101376_bib149","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajhg.2021.01.006","article-title":"Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model","volume":"108","author":"Patrizi","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.preteyeres.2025.101376_bib150","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/humu.24275","article-title":"PRPH2 mutation update: in silico assessment of 245 reported and 7 novel variants in patients with retinal disease","volume":"42","author":"Peeters","year":"2021","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.preteyeres.2025.101376_bib151","doi-asserted-by":"crossref","first-page":"17684","DOI":"10.1073\/pnas.0606197103","article-title":"Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo","volume":"103","author":"Philippe","year":"2006","journal-title":"Proc. Natl. Acad. Sci. - PNAS"},{"key":"10.1016\/j.preteyeres.2025.101376_bib152","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene editing for CEP290 -associated retinal degeneration","volume":"390","author":"Pierce","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preteyeres.2025.101376_bib153","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-vision-102016-061413","article-title":"Vectors and gene delivery to the retina","volume":"3","author":"Planul","year":"2017","journal-title":"Annu. Rev. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib155","first-page":"323","article-title":"Oligochitosan polyplexes as carriers for retinal gene delivery","volume":"48","author":"Puras","year":"2013","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib156","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220776","article-title":"Vision rescue via unconstrained in vivo prime editing in degenerating neural retinas","volume":"220","author":"Qin","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.preteyeres.2025.101376_bib157","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.preteyeres.2025.101376_bib158","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.preteyeres.2025.101376_bib159","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.ymthe.2017.08.018","article-title":"AAV8 can induce innate and adaptive immune response in the primate eye","volume":"25","author":"Reichel","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib160","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1167\/iovs.17-22494","article-title":"Humoral immune response after intravitreal but not after subretinal AAV8 in primates and patients","volume":"59","author":"Reichel","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib162","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib163","series-title":"The First Steps in Seeing","author":"Rodieck","year":"1998"},{"key":"10.1016\/j.preteyeres.2025.101376_bib164","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Rold\u00e3o","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.preteyeres.2025.101376_bib165","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","article-title":"In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels","volume":"39","author":"Rothgangl","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241006","article-title":"The effects of PEGylation on LNP based mRNA delivery to the eye","volume":"15","author":"Ryals","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.preteyeres.2025.101376_bib167","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10633-021-09843-x","article-title":"New criteria for evaluation of electroretinogram in patients with retinitis pigmentosa","volume":"143","author":"Sabbaghi","year":"2021","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2016.04.032","article-title":"Changes in ganglion cells during retinal degeneration","volume":"329","author":"Saha","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.preteyeres.2025.101376_bib169","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3390\/pharmaceutics14091842","article-title":"Non-viral delivery of CRISPR\/cas cargo to the retina using nanoparticles: current possibilities, challenges, and limitations","volume":"14","author":"Salman","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2025.101376_bib170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuron.2010.01.018","article-title":"Design principles of insect and vertebrate visual systems","volume":"66","author":"Sanes","year":"2010","journal-title":"Neuron (Camb., Mass.)"},{"key":"10.1016\/j.preteyeres.2025.101376_bib171","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.omtm.2019.11.016","article-title":"Genome editing in patient iPSCs corrects the most prevalent USH2A mutations and reveals intriguing mutant mRNA expression profiles","volume":"17","author":"Sanjurjo-Soriano","year":"2020","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.preteyeres.2025.101376_bib172","article-title":"USH2A variants causing retinitis pigmentosa or Usher syndrome provoke differential retinal phenotypes in disease-specific organoids","volume":"4","author":"Sanjurjo-Soriano","year":"2023","journal-title":"Hum. Genet. Genomics Adv"},{"key":"10.1016\/j.preteyeres.2025.101376_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.preteyeres.2025.101376_bib174","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/pharmaceutics14040824","article-title":"AAV-CRISPR\/Cas9 gene editing preserves long-term vision in the P23H rat model of autosomal dominant retinitis pigmentosa","volume":"14","author":"Shahin","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.preteyeres.2025.101376_bib175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41392-022-01234-1","article-title":"Dual-AAV split prime editor corrects the mutation and phenotype in mice with inherited retinal degeneration","volume":"8","author":"She","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib176","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1606","article-title":"Suprachoroidal gene transfer with nonviral nanoparticles","volume":"6","author":"Shen","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.preteyeres.2025.101376_bib177","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib178","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature13011","article-title":"DNA interrogation by the CRISPR RNA-guided endonuclease Cas9","volume":"507","author":"Sternberg","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2025.101376_bib179","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-biochem-080320-110356","article-title":"Repair of DNA double-strand breaks by the non-homologous end joining pathway","volume":"90","author":"Stinson","year":"2021","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.preteyeres.2025.101376_bib180","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1152\/physrev.00021.2004","article-title":"The retinal pigment epithelium in visual function","volume":"85","author":"Strauss","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.preteyeres.2025.101376_bib181","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.omtn.2023.02.011","article-title":"In vivo base editing rescues photoreceptors in a mouse model of retinitis pigmentosa","volume":"31","author":"Su","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2025.101376_bib182","doi-asserted-by":"crossref","DOI":"10.1089\/hum.2023.201","article-title":"Knockout and replacement gene surgery to treat rhodopsin-mediated autosomal dominant retinitis pigmentosa","author":"Sun","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib183","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1073\/pnas.88.15.6481","article-title":"Rhodopsin mutations in autosomal dominant retinitis pigmentosa","volume":"88","author":"Sung","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.preteyeres.2025.101376_bib184","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.preteyeres.2025.101376_bib185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2022.01.013","article-title":"Delivery of CRISPR-Cas tools for in vivo genome editing therapy: trends and challenges","volume":"342","author":"Taha","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.preteyeres.2025.101376_bib186","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41587-019-0193-0","article-title":"Continuous evolution of base editors with expanded target compatibility and improved activity","volume":"37","author":"Thuronyi","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib187","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2006.01.104","article-title":"In vivo transduction of murine cerebellar Purkinje cells by HIV-derived lentiviral vectors","volume":"1082","author":"Torashima","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib188","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/s41467-022-29550-8","article-title":"Therapeutic homology-independent targeted integration in retina and liver","volume":"13","author":"Tornabene","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib189","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav4523","article-title":"Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina","volume":"11","author":"Tornabene","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.preteyeres.2025.101376_bib190","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.preteyeres.2014.08.001","article-title":"Vector platforms for gene therapy of inherited retinopathies","volume":"43","author":"Trapani","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib191","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","article-title":"GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases","volume":"33","author":"Tsai","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib192","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ophtha.2018.04.001","article-title":"Clustered regularly interspaced short palindromic repeats-based genome surgery for the treatment of autosomal dominant retinitis pigmentosa","volume":"125","author":"Tsai","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.preteyeres.2025.101376_bib193","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3389\/fnins.2019.00945","article-title":"Gene editing preserves visual functions in a mouse model of retinal degeneration","volume":"13","author":"Vagni","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib194","unstructured":"Variants in gene MERTK - ClinVar Miner [WWW Document], n.d. URL https:\/\/clinvarminer.genetics.utah.edu\/variants-by-gene\/MERTK (accessed 2.28.24)."},{"key":"10.1016\/j.preteyeres.2025.101376_bib195","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib196","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41434-021-00232-2","article-title":"Cas9-directed immune tolerance in humans\u2014a model to evaluate regulatory T cells in gene therapy?","volume":"28","author":"Wagner","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib197","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.aba8853","article-title":"Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants","volume":"368","author":"Walton","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.preteyeres.2025.101376_bib198","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.preteyeres.2025.101376_bib199","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13578-017-0136-8","article-title":"Microhomology-mediated end joining: new players join the team","volume":"7","author":"Wang","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib200","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1038\/s41467-021-26789-5","article-title":"A general theoretical framework to design base editors with reduced bystander effects","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib201","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2021.06.030","article-title":"In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles","volume":"336","author":"Wang","year":"2021","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.preteyeres.2025.101376_bib202","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2020.04.052","article-title":"A pH-responsive silica-metal-organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries","volume":"324","author":"Wang","year":"2020","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.preteyeres.2025.101376_bib203","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/s41467-020-17029-3","article-title":"Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing","volume":"11","author":"Wei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib204","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.bpj.2008.10.016","article-title":"Overexpression of rhodopsin alters the structure and photoresponse of rod photoreceptors","volume":"96","author":"Wen","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.preteyeres.2025.101376_bib205","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1038\/s41598-023-33694-y","article-title":"Modeling rod and cone photoreceptor cell survival in vivo using optical coherence tomography","volume":"13","author":"Whitmore","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.preteyeres.2025.101376_bib206","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/jov.20.10.7","article-title":"Resolution acuity across the visual field for mesopic and scotopic illumination","volume":"20","author":"Wilkinson","year":"2020","journal-title":"J. Vis."},{"key":"10.1016\/j.preteyeres.2025.101376_bib207","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ymthe.2022.02.010","article-title":"CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa","volume":"30","author":"Wu","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib208","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1038\/s41467-023-40655-6","article-title":"AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib209","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1073\/pnas.1821000116","article-title":"AAV cis-regulatory sequences are correlated with ocular toxicity","volume":"116","author":"Xiong","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.preteyeres.2025.101376_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108192","article-title":"Genome editing, a superior therapy for inherited retinal diseases","volume":"206","author":"Yan","year":"2023","journal-title":"Vis. Res."},{"key":"10.1016\/j.preteyeres.2025.101376_bib211","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.actbio.2019.10.037","article-title":"Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina","volume":"101","author":"Yang","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.preteyeres.2025.101376_bib212","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.omtn.2018.03.010","article-title":"Development of a reporter system to explore MMEJ in the context of replacing large genomic fragments","volume":"11","author":"Yanik","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2025.101376_bib213","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nbt.4005","article-title":"Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing","volume":"35","author":"Yin","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.preteyeres.2025.101376_bib214","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.cell.2023.03.034","article-title":"Prediction of efficiencies for diverse prime editing systems in multiple cell types","volume":"186","author":"Yu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.preteyeres.2025.101376_bib215","doi-asserted-by":"crossref","first-page":"14716","DOI":"10.1038\/ncomms14716","article-title":"Nrl knockdown by AAV-delivered CRISPR\/Cas9 prevents retinal degeneration in mice","volume":"8","author":"Yu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.preteyeres.2025.101376_bib216","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.37","article-title":"Off-target effects in CRISPR\/Cas9-mediated genome engineering","volume":"4","author":"Zhang","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.preteyeres.2025.101376_bib217","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ymthe.2022.01.005","article-title":"A flexible split prime editor using truncated reverse transcriptase improves dual-AAV delivery in mouse liver","volume":"30","author":"Zheng","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib218","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ymthe.2019.11.031","article-title":"Rhodopsin genomic loci DNA nanoparticles improve expression and rescue of retinal degeneration in a model for retinitis pigmentosa","volume":"28","author":"Zheng","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib219","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ymthe.2021.07.011","article-title":"Dual-AAV delivering split prime editor system for in vivo genome editing","volume":"30","author":"Zhi","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.preteyeres.2025.101376_bib220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3410\/B2-3","article-title":"Ocular immune privilege","volume":"2","author":"Zhou","year":"2010","journal-title":"F1000 Biol. Rep."}],"container-title":["Progress in Retinal and Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946225000497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1350946225000497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:31:55Z","timestamp":1760855515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1350946225000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":216,"alternative-id":["S1350946225000497"],"URL":"https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101376","relation":{},"ISSN":["1350-9462"],"issn-type":[{"value":"1350-9462","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shining light on CRISPR\/Cas9 therapeutics for inherited retinal diseases","name":"articletitle","label":"Article Title"},{"value":"Progress in Retinal and Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101376"}}